CTRVP

Hepion Pharmaceuticals (PK) (CTRVP)

Hepion Pharmaceuticals Inc (PK)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:CTRVP

<< 前へ 1 2 3 4 5 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2022/06/30	19 : 01	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2022/06/28	22 : 47	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2022/06/27	19 : 06	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2022/06/25	05 : 25	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2022/06/07	05 : 17	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2022/06/01	05 : 53	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2022/05/27	21 : 45	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2022/05/17	05 : 46	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2022/04/30	06 : 29	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2022/04/21	06 : 30	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2022/04/09	06 : 27	Edgar (US Regulatory)	Annual Report (10-k)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2022/02/14	20 : 16	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2022/02/10	22 : 38	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2022/01/20	00 : 49	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2022/01/13	00 : 09	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2022/01/10	20 : 05	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2022/01/04	20 : 01	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2021/12/21	22 : 25	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2021/11/30	22 : 10	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2021/11/26	20 : 09	Edgar (US Regulatory)	Notice of Effectiveness (effect)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2021/11/20	07 : 01	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3/a)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2021/11/16	22 : 54	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2021/11/16	06 : 50	Edgar (US Regulatory)	Quarterly Report (10-q)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2021/10/09	05 : 31	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2021/10/08	05 : 25	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2021/10/01	06 : 23	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2021/09/29	22 : 23	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2021/09/13	21 : 29	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2021/09/07	19 : 00	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)
2021/08/23	22 : 20	Edgar (US Regulatory)	Current Report Filing (8-k)	USOTC:CTRVP	Hepion Pharmaceuticals Inc (PK)